Inventor · disambiguated record
Matthew Fraser
Also filed as: FRASER MATTHEW O · FRASER MATTHEW OLIVER
9 granted patents·25 pending applications·366 citations·filing 2002–2017
90Inventor score
Files withDYNOGEN PHARMACEUTICALS INC22CHANCELLOR MICHAEL B2DYNOGEN PHARMACUETICALS INC2FRASER MATTHEW O2UNIV PITTSBURGH2
Top patents by PatentIndex Score
34 records- 0196US7063860B2Application of lipid vehicles and use for drug deliveryUNIV PITTSBURGH·Filed 2002·Granted Jun 20, 2006·233 cites·4 claims
- 0295US7041704B2Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2005·Granted May 9, 2006·34 cites·9 claims
- 0391US6846823B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2005·50 cites·62 claims
- 0489US8110217B2Sphingomyelin liposomes for the treatment of hyperactive bladder disordersCHANCELLOR MICHAEL B·Filed 2006·Granted Feb 7, 2012·13 cites·9 claims
- 0583US7459430B2Methods of using ziconotide to treat overactive bladderDYNOGEN PHARMACEUTICALS INC·Filed 2006·Granted Dec 2, 2008·2 cites·14 claims
- 0683US7084116B2Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Aug 1, 2006·13 cites·14 claims
- 0780US7125848B2Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 24, 2006·9 cites·14 claims
- 0879US7115606B2Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted Oct 3, 2006·11 cites·16 claims
- 0968US7223754B2Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Granted May 29, 2007·1 cites·16 claims
- 1063US2007066597A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disordersDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1161US2005107353A1Methods of treating lower urinary tract disorders using losigamoneDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1260US2008275080A1Methods for treating lower urinary tract disorders using alpha2delta subunit channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2008·Application pending·0 cites
- 1360US2008085916A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1460US2007003610A1Application of lipid vehicles and use for drug deliveryUNIV PITTSBURGH·Filed 2006·Application pending·0 cites
- 1559US2004209960A1Methods of treating lower urinary tract disorders using sodium channell modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1658US2004213842A1Methods of treating gastrointestinal tract disorders using sodium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1758US2006188575A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1858US2005054725A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1957US2007060652A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2056US2005228049A1Methods for decreasing detrusorDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2156US2004142034A1Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2256US2006247311A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2355US2005113421A1Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2454US2005239890A1Methods for decreasing detrusor muscle overactivityDYNOGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2554US2004248979A1Method of treating lower urinary tract disordersDYNOGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2653US2005282799A1Method of treating lower urinary tract disordersDYNOGEN INC·Filed 2005·Application pending·0 cites
- 2753US2005272719A1Method for inhibiting detrusor muscle overactivityLANDAU STEVEN B·Filed 2005·Application pending·0 cites
- 2853US2012128762A1Sphingomyelin Liposomes for the Treatment of Hyperactive Bladder DisordersCHANCELLOR MICHAEL B·Filed 2012·Application pending·0 cites
- 2952US2004198822A1Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulatorsDYNOGEN PHARMACUETICALS INC·Filed 2004·Application pending·0 cites
- 3052US2011294881A1METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORSFRASER MATTHEW OLIVER·Filed 2011·Application pending·0 cites
- 3151US2007105785A1Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulatorsDYNOGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3248US2006276542A1Methods for treating functional bowel disorders using alpha2 subunit calcium channel modulators with smooth muscle modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 3348US2006264509A1Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulatorsFRASER MATTHEW O·Filed 2004·Application pending·0 cites
- 3445US2017290773A1Sphingomyelin liposomes for the treatment of hyperactive bladder disordersUNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Fraser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →